Serial Number
99572306
Owner
Moexa Pharmaceuticals LimitedAttorney
Joseph G. ChuFiling Date
Dec 30, 2025
MOEXA Trademark
Serial Number: 99572306
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Joseph G. Chu JCIP
155 N Lake Avenue, Suite 800
Pasadena, CA 91101
United States
Trademark Details
Filing Date
December 30, 2025
Registration Date
Not Registered
Published for Opposition
September 1, 2026
Goods & Services
Pharmaceutical preparations for the treatment and prevention of cancer and fibrosis; Pharmaceutical preparations for medical purposes, namely, for treatment and prevention of lung cancer, colorectal cancer, lymph node cancer, bone cancer, gastric cancer, melanoma, pancreatic cancer, breast cancer, liver cancer, prostate cancer, pulmonary fibrosis, idiopathic pulmonary fibrosis, post-viral fibrosis, post coronavirus fibrosis, cystic fibrosis or fibrosis resulting from radiation, renal fibrosis, cardiac fibrosis, liver fibrosis, arthrofibrosis, nephrogenic systemic fibrosis, retroperitoneal fibrosis, scleroderma/systemic sclerosis, myelofibrosis or mediastinal fibrosis, fibrosis associated with arterial stiffness, Crohn's disease, Dupuytren's contracture, keloids, Peyronie's disease or adhesive capsulitis, and inflammation of the body of a human subject; Medical preparations for the treatment of cancer and fibrosis; Veterinary pharmaceutical preparations for the treatment of cancer and fibrosis; Medicaments for the treatment and prevention of cancer and fibrosis; Anti-cancer preparations; Medicaments for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment, inhibition or prevention of cell proliferation; chemical preparations and medicaments for pharmaceutical or medical purposes, namely, for treatment, inhibition or prevention of cancer and fibrosis; Veterinary pharmaceutical preparations for the prevention of cancer and fibrosis; Pharmaceutical preparations for the prevention of cell proliferation; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the prevention of fibrosis; Medicaments for the prevention of fibrosis; Dietetic foods adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic pet foods adapted for veterinary use; Dietetic pet foods adapted for veterinary purposes; Dietary supplements for humans and animals; Pharmaceutical preparations for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for the prevention of cell proliferation; Medicaments for the prevention of cancer